首页> 美国卫生研究院文献>ACS AuthorChoice >Duplex Microfluidic SERS Detection of Pathogen Antigenswith Nanoyeast Single-Chain Variable Fragments
【2h】

Duplex Microfluidic SERS Detection of Pathogen Antigenswith Nanoyeast Single-Chain Variable Fragments

机译:双重微流控SERS检测病原体抗原与纳米酵母单链可变片段

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Quantitative and accurate detection of multiple biomarkers would allow for the rapid diagnosis and treatment of diseases induced by pathogens. Monoclonal antibodies are standard affinity reagents applied for biomarkers detection; however, their production is expensive and labor-intensive. Herein, we report on newly developed nanoyeast single-chain variable fragments (NYscFv) as an attractive alternative to monoclonal antibodies, which offers the unique advantage of a cost-effective production, stability in solution, and target-specificity. By combination of surface-enhanced Raman scattering (SERS) microspectroscopy using glass-coated, highly purified SERS nanoparticle clusters as labels, with a microfluidic device comprising multiple channels, a robust platform for the sensitive duplex detection of pathogen antigens has been developed. Highly sensitive detection for individual Entamoeba histolytica antigen EHI_115350 (limit of detection = 1 pg/mL, corresponding to 58.8 fM) and EHI_182030 (10 pg/mL, corresponding 453 fM) with high specificity has been achieved, employing the newly developed corresponding NYscFv as probe in combination with SERS microspectroscopyat a single laser excitation wavelength. Our first report on SERS-basedimmunoassays using the novel NYscFv affinity reagent demonstratesthe flexibility of NYscFv fragments as viable alternatives to monoclonalantibodies in a range of bioassay platforms and paves the way forfurther applications.
机译:多种生物标志物的定量和准确检测将允许快速诊断和治疗由病原体引起的疾病。单克隆抗体是用于生物标记检测的标准亲和试剂;但是,它们的生产昂贵且劳动强度大。在本文中,我们报道了最新开发的纳米酵母单链可变片段(NYscFv),作为单克隆抗体的诱人替代品,它提供了具有成本效益的生产,溶液稳定性和靶标特异性的独特优势。通过使用玻璃涂层,高度纯化的SERS纳米粒子簇作为标记的表面增强拉曼散射(SERS)显微光谱与包含多个通道的微流体装置相结合,已经开发出了用于病原体抗原的灵敏双重检测的强大平台。使用新开发的相应NYscFv作为抗体,已实现了高特异性的高特异性检测单个溶组织变形杆菌抗原EHI_115350(检测限= 1 pg / mL,对应于58.8 fM)和EHI_182030(10 pg / mL,对应于453 fM)。探针与SERS光谱学结合在单个激光激发波长下。我们关于基于SERS的第一份报告新型NYscFv亲和试剂的免疫测定证明NYscFv片段的灵活性可作为单克隆的可行替代品一系列生物测定平台中的抗体,为进一步的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号